Alpha 2.0
Login Register
» Articles » PMID: 32285011

Quantifying the Use of Connected Digital Products in Clinical Research

Overview
Journal NPJ Digit Med
Specialty Medical Informatics
Date 2020 Apr 15
PMID 32285011
Citations 44
Authors
Caroline Marra
Jacqueline L Chen
Andrea Coravos
Ariel D Stern
Affiliations
Soon will be listed here.
Abstract

Over recent years, the adoption of connected technologies has grown dramatically, with potential for improving health care delivery, research, and patient experience. Yet, little has been documented about the prevalence and use of connected digital products (e.g., products that capture physiological and behavioral metrics) in formal clinical research. Using 18 years of data from ClinicalTrials.gov, we document substantial growth in the use of connected digital products in clinical trials (~34% CAGR) and show that these products have been used across all phases of research and by a diverse group of trial sponsors. We identify four distinct use cases for how such connected products have been integrated within clinical trial design and suggest implications for various stakeholders engaging in clinical research.

Citing Articles

Urban-Suburban Differences in Public Perspectives on Digitalizing Pediatric Research: Cross-Sectional Survey Study.

Fang H, Xian R, Li J, Li Y, Liu E, Zhao Y J Med Internet Res. 2025; 27():e60324.

PMID: 39773676 PMC: 11751655. DOI: 10.2196/60324.

Exploring the Potential of Electronic Patient-Generated Health Data for Evaluating Treatment Response to Intramuscular Steroids in Rheumatoid Arthritis: Case Series.

Al-Attar M, Assawamartbunlue K, Gandrup J, van der Veer S, Dixon W JMIR Form Res. 2024; 8:e55715.

PMID: 39467551 PMC: 11555448. DOI: 10.2196/55715.

Patient-centricity in digital measure development: co-evolution of best practice and regulatory guidance.

Aryal S, Blankenship J, Bachman S, Hwang S, Zhai Y, Richards J NPJ Digit Med. 2024; 7(1):128.

PMID: 38755349 PMC: 11099175. DOI: 10.1038/s41746-024-01110-y.

Digital Health Technology (DHT) in European Clinical Trials, How to Improve the Status-Quo of the Regulatory Landscape?.

Podhaisky H Ther Innov Regul Sci. 2024; 58(4):610-613.

PMID: 38656468 DOI: 10.1007/s43441-024-00657-y.

Remote digital health technologies for improving the care of people with respiratory disorders.

Dunn J, Coravos A, Fanarjian M, Ginsburg G, Steinhubl S Lancet Digit Health. 2024; 6(4):e291-e298.

PMID: 38402128 PMC: 10960683. DOI: 10.1016/S2589-7500(23)00248-0.

References
1.
Coravos A, Khozin S, Mandl K . Developing and adopting safe and effective digital biomarkers to improve patient outcomes. NPJ Digit Med. 2019; 2(1). PMC: 6411051. DOI: 10.1038/s41746-019-0090-4. View
2.
Coravos A, Goldsack J, Karlin D, Nebeker C, Perakslis E, Zimmerman N . Digital Medicine: A Primer on Measurement. Digit Biomark. 2020; 3(2):31-71. PMC: 7015383. DOI: 10.1159/000500413. View
3.
Khozin S, Coravos A . Decentralized Trials in the Age of Real-World Evidence and Inclusivity in Clinical Investigations. Clin Pharmacol Ther. 2019; 106(1):25-27. DOI: 10.1002/cpt.1441. View
4.
Dodge H, Zhu J, Mattek N, Austin D, Kornfeld J, Kaye J . Use of High-Frequency In-Home Monitoring Data May Reduce Sample Sizes Needed in Clinical Trials. PLoS One. 2015; 10(9):e0138095. PMC: 4574479. DOI: 10.1371/journal.pone.0138095. View
5.
Bakker J, Goldsack J, Clarke M, Coravos A, Geoghegan C, Godfrey A . A systematic review of feasibility studies promoting the use of mobile technologies in clinical research. NPJ Digit Med. 2019; 2:47. PMC: 6554345. DOI: 10.1038/s41746-019-0125-x. View